Abdul-Aziz Khalil, Faizal Abdul-Aziz
Regional Department of Immunology, Heart of England NHS Foundation Trust, Birmingham, United Kingdom.
Saudi Med J. 2005 Dec;26(12):1875-81.
Autoimmune hepatobiliary diseases AIHBD comprise autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis and the overlap syndromes. Early diagnosis and treatment of AIHBD are essential for the prevention of the high morbidity, and mortality, that is, otherwise, associated with untreated patients. Screening for AIHBD relies heavily on the use of serological tests for the detection of serum autoantibodies that associate with the diseases. Understanding these tests, and the results produced, is important for the efficient diagnosis/exclusion of these diseases. In this review, we discuss the various tests available in the clinical immunology laboratory for screening of AIHBD and comment on the significance of the results produced by each test. We hope that this review will highlight this group of autoimmune diseases and lead to more efficient and earlier diagnosis, and treatment, of patients with AIHBD.
自身免疫性肝胆疾病(AIHBD)包括自身免疫性肝炎、原发性胆汁性肝硬化、原发性硬化性胆管炎以及重叠综合征。对AIHBD进行早期诊断和治疗对于预防高发病率和死亡率至关重要,否则,未治疗的患者会面临这些风险。AIHBD的筛查在很大程度上依赖于使用血清学检测来检测与这些疾病相关的血清自身抗体。了解这些检测方法及其产生的结果对于有效诊断/排除这些疾病很重要。在本综述中,我们讨论了临床免疫实验室中可用于筛查AIHBD的各种检测方法,并对每种检测方法产生的结果的意义进行了评论。我们希望本综述能突出这组自身免疫性疾病,并导致对AIHBD患者进行更有效、更早的诊断和治疗。